Literature DB >> 10102613

Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors.

J W Hussong1, M Brown, S L Perkins, L P Dehner, C M Coffin.   

Abstract

Inflammatory myofibroblastic tumors (IMTs) are uncommon spindle cell proliferations that occur in the viscera and soft tissue of children and young adults. Their biologic potential is indeterminate: 25% of IMTs recur, and rare examples undergo malignant transformation (MT). This study investigates histologic features, DNA ploidy, and expression of apoptotic regulatory and oncogenic proteins in IMTs in an attempt to identify those deviances that might correlate with aggressive behavior or MT. Twenty-four formalin-fixed, paraffin-embedded IMTs for which clinical outcome was known were evaluated for cellularity, cytologic atypia, mitoses, ganglion-like cells, inflammatory infiltrate, DNA ploidy by flow cytometric examination, and bax, bcl-2, p53, and c-myc expression by immunohistochemical analysis. Sixteen (67%) of the IMTs did not recur, 6 (25%) recurred, and 2 (8%) underwent MT. Cellular atypia was observed in 69% of the cases without recurrence, 100% with recurrence, and 100% with MT. Ganglion-like cells were present in 56, 100, and 100% of the IMTs without recurrence, with recurrence, and with MT, respectively. There was no difference in the degree of cellularity, mitoses, or inflammatory infiltrate among the outcome groups. All of the tumors expressed bax, and none expressed c-myc. Two (8%) were immunoreactive for p53, one of which recurred and one of which underwent MT. bcl-2 expression was observed in 9 (37%) of the IMTs, with no difference among the three groups. Two IMTs were aneuploid, one of which underwent MT. Neither morphologic evaluation for cellularity, mitosis, or inflammatory infiltrate nor expression of bax or c-myc were useful for prediction of clinical outcome. The combination of atypia, ganglion-like cells, p53 expression and DNA ploidy analysis, however, might be useful to identify IMTs that might undergo MT or pursue a more aggressive clinical course with recurrences.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102613

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  41 in total

1.  Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms.

Authors:  M Ladanyi
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Unusual case of pancreatic inflammatory myofibroblastic tumor associated with spontaneous splenic rupture.

Authors:  Kamal S Hassan; Hector I Cohen; Fadi K Hassan; Shadi K Hassan
Journal:  World J Emerg Surg       Date:  2010-11-22       Impact factor: 5.469

3.  Primary Inflammatory Myofibroblastic Tumors of the Breast with Metastasis: Radiographic and Histopathologic Predictive Factors.

Authors:  Eun Jung Choi; Gong Yong Jin; Myoung Ja Chung; Woo Sung Moon; Hyun Jo Youn
Journal:  J Breast Cancer       Date:  2015-06-26       Impact factor: 3.588

Review 4.  Inflammatory myofibroblastic tumors of the nasal cavity and paranasal sinus: a clinicopathologic study of 25 cases and review of the literature.

Authors:  Chun-Yan He; Ge-Hong Dong; Dong-Mei Yang; Hong-Gang Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

5.  [Inflammatory myofibroblastic tumor of the greater omentum in a 1.5-year-old boy].

Authors:  K Backhaus; S Grasshoff-Derr; K Ernestus; T Meyer
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

6.  What's new in the AFIP fascicle on salivary gland tumors: a few highlights from the 4th Series Atlas.

Authors:  Gary L Ellis
Journal:  Head Neck Pathol       Date:  2009-07-21

Review 7.  ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.

Authors:  Chien-Feng Li; Hsuan-Ying Huang; Mei-Jun Zhu; Jen-Chieh Lee; Adrián Mariño-Enríquez; Chung-Ta Lee; Wen-Bin Ou; Jason L Hornick; Jonathan A Fletcher
Journal:  J Pathol       Date:  2016-12-15       Impact factor: 7.996

8.  Pulmonary "inflammatory myofibroblastic" tumors: a critical examination of the diagnostic category based on quantitative immunohistochemical analysis.

Authors:  A B Farris; E J Mark; R L Kradin
Journal:  Virchows Arch       Date:  2007-03-20       Impact factor: 4.064

9.  Inflammatory myofibroblastic tumor in the head of the pancreas with anorexia and vomiting in a 69-year-old man: A case report.

Authors:  Ding Ding; Xianmin Bu; Feng Tian
Journal:  Oncol Lett       Date:  2016-06-28       Impact factor: 2.967

10.  Anaplasic lymphoma kinase positive inflammatory myofibroblastic tumour with renal pelvic calculus: a case report.

Authors:  Hinde Elfatemi; Chbani Laila; Kaoutar Znati; Mohamed Fadl Tazi; Youness Ahallal; Elmehdi Tazi; Moulay Hassan Farih; Afaf Amarti
Journal:  Cases J       Date:  2009-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.